The goal of this investigational study is to determine if Systane PRO Preservative Free is non-inferior to BLINK TRIPLE CARE in the clinically significant improvement of signs and symptoms of dry eye in patients over 4 weeks.
Age: Adults ≥ 18 years.
Diagnosis: Clinical diagnosis of mild to moderate dry eye disease in at least one eye with OSDI ≥ 13 to ≤ 32 at screening.
OSDI ≥ 13 to ≤ 32 at screening.
Objective evidence: NITBUT ≤ 10 seconds in the study eye(s) at screening.
Active ocular infection or inflammation unrelated to DED (e.g., bacterial/viral conjunctivitis, active uveitis).
Severe ocular surface disease beyond typical DED (e.g., severe keratitis, Stevens-Johnson syndrome, ocular cicatricial pemphigoid).
Excessive corneal staining: CFS > grade 3 in the study eye(s).
Recent ocular surgery or procedure: ocular surgery, laser, or punctal occlusion within 6 months prior to screening.